Phosphatidylserine for Adhd Support

Research suggests that phosphatidylserine may offer modest benefits for certain ADHD-related symptoms in children, particularly inattention and some aspects of behavioral dysregulation, with the most consistent signals emerging from randomized controlled trials and a meta-analysis that together found statistically significant but generally modest improvements, especially when phosphatidylserine is combined with omega-3 fatty acids like DHA or EPA. Studies indicate that this combined form may outperform phosphatidylserine alone, and a network meta-analysis ranking multiple supplements placed phosphatidylserine among those with stronger signals for attention improvement. However, the evidence has meaningful limitations: the overall quality of studies is rated as low, sample sizes are often small, and one head-to-head trial found that phosphatidylserine did not improve core ADHD symptoms as effectively as an established medication, though it did show some benefit for broader behavioral difficulties; additionally, a 2024 trial in children with both epilepsy and ADHD found no benefit, and a case report raised caution about combining these supplements with stimulant medications in children. The existing body of evidence is preliminary and does not yet support firm clinical conclusions, meaning individuals considering phosphatidylserine for ADHD support should consult a qualified healthcare provider before doing so.